Elevated levels of interferon-α act directly on B cells to breach multiple tolerance mechanisms promoting autoantibody production.

The results provide evidence that elevated IFNα levels act directly on B cells to facilitate autoantibody production and further highlight the importance of IFN signaling as a potential therapeutic target in SLE. This article is protected by copyright. All rights reserved.